Trial record 1 of 1 for:
NCT04796012
VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04796012 |
|
Recruitment Status :
Recruiting
First Posted : March 12, 2021
Last Update Posted : May 16, 2024
|
Sponsor:
University of Texas Southwestern Medical Center
Information provided by (Responsible Party):
Matthew Campbell, University of Texas Southwestern Medical Center
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | January 2025 |
| Estimated Study Completion Date : | January 2025 |